Against all odds, researchers developed an RNA drug to "silence" a defective gene copy, offering a path to improved quality of life for a child with a rare developmental disorder.

Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral portfolio with a Phase III drug designed ...

Scientists tested the substance on rats with positive results and are now seeking partnerships with pharmaceutical companies to conduct clinical trials. A research team at the Federal University of AB ...

New research reveals metformin may reduce exercise benefits for diabetes patients, affecting blood sugar control and fitness ...

The U.S. Food and Drug Administration (FDA) is eliminating the prominent "black box" warnings on many hormone replacement ...

Doctors suggest a mix of aerobic exercise, such as running or walking, and strength training, which slows the loss of bone ...

NEW ORLEANS — It is said, "A mother's love is a force that can move mountains." It was a year ago that we brought you the ...

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

Ghyslain Mombo-Ngoma, MD, PhD, led a study in Gabon in which researchers gave a single-dose treatment combining an ...

Hundreds of people are on a waitlist for opioid addiction treatment in Los Angeles County jails as the state presses the ...

When your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they ...

America’s opioid epidemic has been a prolonged public health crisis, resulting in countless overdose deaths and billions in ...